Non-muscle invasive bladder cancer Flashcards
What are the demographics of NMIBC?
Caucasian american men (3:1) older than 65 years of age
What are the risk factors for bladder cancer?
Tobacco smoking Aromatic amines polycyclic hydrocarbons Arsenic Cyclophosphamide
Lynch syndrome
Schistosoma hematobium (sqaumous cell) Aristocholic acid (upper tracts)
What are some common mutations of tumor suppressor genes found in NMIBC?
GSTM-1 NAT-2 P16 CDKN2A PTEN RB1 TP53
What are some oncogene mutations seen in NMIBC?
FGFR3
PIK3CA
RAS
What is the rate of urinary tract malignancy in patient with asymptomatic microscopic hematuria?
2.6%
What are the common presenting symptoms of NMIBC?
Hematuria
irritative voiding symptoms
What is Ta bladder cancer?
Non invasive papillary carcinoma
What is Tis bladder cancer?
Carcinoma in situ
What is T1 bladder cancer?
Tumor invades the lamina propria
What is T2a bladder cancer?
Tumor invades the muscularis propria inner half
What is T2b bladder cancer?
Tumor invades deep muscularis propria (outer half)
What is T3a bladder cancer?
Tumor invades perivesical fat microscopically
What is T3b bladder cancer?
Tumor invades perivesical fat macroscopically
What is T4a bladder cancer?
Tumor invades adjacent organs
What is T4b bladder cancer?
Tumor invades pelvic side wall.
What is the 10 year survival prognosis for high grade NMIBC?
70-85%
What are the recurrence and progression rates for Ta NMIBC?
Recurrence: 55%
Progression: 6%
What are the recurrence and progression rates for T1 high grade NMIBC?
Recurrence: 45%
Progression: 17%
What defines low risk NMIBC?
Low grade
Solitary lesion
Ta < 3cm
Papillary urothelial neoplasm of low malignant potential
What defines intermediate risk NMIBC?
Recurrent low grade Ta within 1 year Solitary LG Ta > 3cm Multifocal LG Ta HG Ta < 3cm LG T1
What defines high risk NMIBC?
HG T1
Recurrent HG Ta
HG Ta > 3cm or multifocal
CIS
BCG failure in HG patient
Any variant histology
LVI
HG prostatic urethral involvement
How should NMIBC be diagnosed?
By thorough cystoscopy.
What should be the initial treatment of NMIBC?
At initial diagnosis of a patient with bladder cancer, a clinician should perform complete visual resection of the bladder tumor(s), when technically feasible
What should be included in addition to cystoscopy for evaluation of hematuria or a suspected bladder tumor?
Upper tract imaging.
What should be done if a patient has a normal cystoscopy but positive cytology?
Prostatic urethral biopsies Upper tract imaging Ureteroscopy Blue light cystoscopy Random bladder biopsies
What should be done if NMIBC shows variant histology?
Repeat TURBT in 4-6 weeks.
What is the rate of muscle invasion with variant histology?
86%
What is the preferred tx option for NMIBC with variant histology?
Due to the high rate of upstaging associated with variant histology, a clinician should consider offering initial radical cystectomy
What are the 5 FDA approved tumor markers?
NMP22 BTA Urovysion FISH Immunocyt Cxbladder
What is the role of urinary biomarkers in NMIBC?
In surveillance of NMIBC, a clinician should not use urinary biomarkers in place of cystoscopic evaluation.
What is the role of urinary biomarkers during surveillance for low risk NMIBC?
In a patient with a history of low-risk cancer and a normal cystoscopy, a clinician should not routinely use a urinary biomarker or cytology during surveillance.
What is the indication for urinary biomarkers in NMIBC?
In a patient with NMIBC, a clinician may use biomarkers to assess response to intravesical BCG (UroVysion® FISH) and adjudicate equivocal cytology (UroVysion® FISH and ImmunoCyt™). (Expert Opinion)
What should be done for a patient with NMIBC who underwent an incomplete initial resection?
Repeat TURBT if feasible.
What is the next step for high risk, high grade, Ta tumors after resection?
Repeat TURBT in 6 weeks.
What percentage of T1 tumors get upstaged?
30%
What is the next step after resection of a T1 NMIBC?
Repeat TURBT in 6 weeks.
What percentage of high grade Ta NMIBC get upstaged?
15%
What percentage of high grade Ta NMIBC have residual tumor?
50%